The Platinum Hall of Fame European Urology would like to recognize our award-winning authors and exceptional reviewers who have helped us achieve a Platinum Level. Best Scientific Paper Prizes 2000 to the Present
2005
2000
DD3PCA3 RNA Analysis in Urine – A New Perspective for Detecting Prostate Cancer
Laparoscopic Radical Prostatectomy: Technical and Early Oncological Assessment of 40 Operations B. Guillonneau, X. Cathelineau, E. Barret, F. Rozet, G. Vallancien European Urology 1999;36:14–20
2001 RPLND or Primary Chemotherapy in Clinical Stage IIA/B Nonseminomatous Germ Cell Tumors? Results of a Prospective Multicenter Trial Including Quality of Life Assessment L. Weissbach, R. Bussar-Maatz, H. Flechtner, U. Pichlmeier, M. Hartmann, L. Keller European Urology 2000;37:582–594
2002 Nonrandomized Comparison of Open Flank versus Laparoscopic Nephrectomy in 249 Patients with Benign Renal Disease P. Fornara, C. Doehn, H.-J. Friedrich, D. Jocham European Urology 2001;40:24–31
2003 Laparoscopic Dismembered Pyeloplasty – The Method of Choice in the Presence of an Enlarged Renal Pelvis and Crossing Vessels I. A. Türk, J. W. Davis, B. Winkelmann, S. Deger, F. Richter, M. D. Fabrizio, B. Schönberger, G. H. Jordan, S. A. Loening European Urology 2002;42:268–275
2004 The Side Effects of Bacillus Calmette-Guérin in the Treatment of Ta T1 Bladder Cancer do not Predict its Efficacy: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial R. J. Sylvester, A. P. M. Van Der Meijden, W. Oosterlinck, W. Hoeltl, A. V. Bono European Urology 2003;44:423–428
& Maintenance Bacillus Calmette-Guérin for Ta T1 Bladder Tumors is not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial A. P. M. Van Der Meijden, R. J. Sylvester, W. Oosterlinck, W. Hoeltl, A. V. Bono European Urology 2003;44:429–434
M. Tinzl, M. Marberger, S. Horvath, C. Chypre European Urology 2004;46:182–186
2006 Prevalence of Asymptomatic Coronary Artery Disease in Men with Vasculogenic Erectile Dysfunction: A Prospective Angiographic Study C. Vlachopoulos, K. Rokkas, N. Ioakeimidis, C. Aggeli, A. Michaelides, G. Roussakis, C. Fassoulakis, A. Askitis, C. Stefanadis European Urology 2005;48:996–1002
2007 Excellent Long-Term Cancer Control with Elective Nephron-Sparing Surgery for Selected Renal Cell Carcinomas Measuring More Than 4 cm F. Becker, S. Siemer, M. Hack, U. Humke, M. Ziegler, M. Stöckle European Urology 2006;49:1058–1064
& Elective Nephron-Sparing Surgery Should Become Standard Treatment for Small Unilateral Renal Cell Carcinoma: Long-term Survival Data of 216 Patients F. Becker, S. Siemer, U. Humke, M. Hack, M. Ziegler, M. Stöckle European Urology 2006;49:308–313
2008 Morbidity and Clinical Outcome of Nephron-Sparing Surgery in Relation to Tumour Size and Indication J.-J. Patard, A. J. Pantuck, M. Crepel, J. S. Lam, L. Bellec, B. Albouy, D. Lopes, J.-C. Bernhard, F. Guillé, B. Lacroix, A. De La Taille, L. Salomon, C. Pfister, M. Soulié, J. Tostain, J.-M. Ferriere, C. C. Abbou, M. Colombel, A. S. Belldegrun European Urology 2007;52:148–154
2009 The Template of the Primary Lymphatic Landing Sites of the Prostate Should Be Revisited: Results of a Multimodality Mapping Study A. Mattei , F. G. Fuechsel, N. Bhatta Dhar, S. H. Warncke, G. N. Thalmann, T. Krause, U. E. Studer European Urology 2008;53:118–125
2010 Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) Classification of Renal Tumours in Patients who are Candidates for Nephron-Sparing Surgery V. Ficarra, G. Novara, S. Secco, V. Macchi, A. Porzionato, R. De Caro, W. Artibani European Urology 2009;56:786–793 Sponsored By Elsevier
The Platinum Hall of Fame Best Clinical Research Paper Published for an author under 35
2007 Frozen Section for the Management of Intraoperatively Detected Palpable Tumor Lesions During Nerve-Sparing Scheduled Radical Prostatectomy C. Eichelberg, A. Erbersdobler, A. Haese, T. Schlomm, F. K. H. Chun, E. Currlin, J. Walz, T. Steuber, M. Graefen, H. Huland European Urology 2006;49:1011–1018
2008
2009 Marked Gene Transcript Level Alterations Occur Early During Radical Prostatectomy T. Schlomm, E. Näkel, A. Lübke, A. Buness, F. K.-H. Chun, T. Steuber, M. Graefen, R. Simon, G. Sauter, A. Poustka, H. Huland, A. Erbersdobler, H. Sültmann, O. J. C. Hellwinkel European Urology 2008;53:333–346
2010 Characteristics of Spontaneous Activity in the Bladder Trigone A. Roosen, C. Wu, G. Sui, R. A. Chowdhury, P. M. Patel, C. H. Fry European Urology 2009;56:346–354 Sponsored By Elsevier
Use of Haemostatic Agents and Glues during Laparoscopic Partial Nephrectomy: A Multi-Institutional Survey from the United States and Europe of 1347 Cases
Residents’ Corner
A. Breda, S. V. Stepanian, J. S. Lam, J. C. Liao, I. S. Gill, J. R. Colombo, G. Guazzoni, M. D. Stifelman, K. T. Perry, A. Celia, G. Breda, P. Fornara, S. V. Jackman, A. Rosales, J. Palou, M. Grasso, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C. C. Abbou, R. Gaston, G. Janetschek, N. A. Soomro, J. J. De la Rosette, P. M. Laguna, P. G. Schulam European Urology 2007;52:798–803
Initial Biopsy Outcome Prediction—Head-to-Head Comparison of a Logistic Regression-Based Nomogram versus Artificial Neural Network
2008
F. K.-H. Chun, M. Graefen, A. Briganti, A. Gallina, J. Hopp, M. W. Kattan, H. Huland, P. I. Karakiewicz European Urology 2007;51:1236–1243
Predictive Factors for Progression in Patients with Clinical Stage T1a Prostate Cancer in the PSA Era
& hK2 and Free PSA, a Prognostic Combination in Predicting Minimal Prostate Cancer in Screen-Detected Men within the PSA Range 4–10 ng/ml
A. Descazeaud, M. Peyromaure, A. Salin, D. Amsellem-Ouazana, T. Flam, A. Viellefond, B. Debré, M. Zerbib European Urology 2008;53:355–362
R. Raaijmakers, S. H. de Vries, B. G. Blijenberg, M. F. Wildhagen, R. Postma, C. H. Bangma, C. Darte, F. H. Schröder European Urology 2007;52:1358–1364
2010
Evaluation of Prostate Cancer Detection with Ultrasound Real-Time Elastography: A Comparison with Step Section Pathological Analysis after Radical Prostatectomy
2009
Should All Patients with Non–Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study S. Gudjónsson, L. Adell, F. Merdasa, R. Olsson, B. Larsson, T. Davidsson, J. Richthoff, G. Hagberg, M. Grabe, P. O. Bendahl, W. Månsson, F. Liedberg European Urology 2009;55:773–780 Sponsored By Eli Lilly
Best Fundamental Research Paper Published for an author under 35
2009
G. Salomon, J. Köllerman, I. Thederan, F. K. H. Chun, L. Budäus, T. Schlomm, H. Isbarn, H. Heinzer, H. Huland, M. Graefen European Urology 2008;54:1354–1362
& Radical Prostatectomy for Incidental (Stage T1a–T1b) Prostate Cancer: Analysis of Predictors for Residual Disease and Biochemical Recurrence U. Capitanio, V. Scattoni, M. Freschi, A. Briganti, A. Salonia, A. Gallina, R. Colombo, P. I. Karakiewicz, P. Rigatti, F. Montorsi European Urology 2008;54:118–125
2007
2010
Depressed Contractile Responses to Neurokinin A in Idiopathic but not Neurogenic Overactive Human Detrusor Muscle
Influence of Nerve Transsections and Combined Bladder Filling on Intravesical Electrostimulation-Induced Bladder Contraction in the Rat
D. J. Sellers, C. R. Chapple, D. P. W. Hay, R. Chess-Williams European Urology 2006;49:510–518
F. De Bock, S. De Wachter, J. J. Wyndaele European Urology 2009;56:527–533 Sponsored By Eli Lilly
2008
& The Role of Biopsy Core Number in Selecting Prostate Cancer Patients for Active Surveillance
Effects of the M3 Receptor Selective Muscarinic Antagonist Darifenacin on Bladder Afferent Activity of the Rat Pelvic Nerve K. Iijima, S. De Wachter, J.-J. Wyndaele European Urology 2007;52:842–849
G. Ploussard, E. Xylinas, L. Salomon, Y. Allory, D. Vordos, A. Hoznek, C.-C. Abbou, A. de la Taille European Urology 2009;56:891–898 Sponsored By Eli Lilly
The Platinum Hall of Fame Platinum Award Winners 2009 1. 2.
Fritz Schröder Urs Studer
Platinum Award Winners 2010 1. 2. 3.
Christopher Chapple Oliver Hakenberg Rodolfo Montironi
2007 Reviewers of the Month January: Massimo Maffezzini (Italy) February: Hiten R. H. Patel (UK) March: Pierre Karakiewicz (Canada) April: Christian Gratzke (Germany) May: Fred Witjes (The Netherlands) June: Ziya Kirkali (Turkey) July: Bertrand Guillonneau (USA) August: Chris Chapple (UK) September: Axel Heidenreich (Germany) October: Jean-Jacques Patard (France) November: Oliver Reich (Germany)
Reviewer of the Year 2007
September: Patrick Bastian (Germany) October: Rafael Badalyan (Armenia) November: Henk van der Poel (The Netherlands)
Reviewer of the Year 2008 Pierre Karakiewicz (Canada)
2009 Reviewers of the Month January: Matthew Gettman (USA) February: Oliver Hakenberg (Germany) March: Riccardo Autorino (Italy) April: Urs Studer (Switzerland) May: Fritz Schröder (The Netherlands) June: Petrisor Geavlete (Romania) July: Clare Fowler (UK) August: Francisco Cruz (Portugal) September: John Denstedt (Canada) October: Jacques Irani (France) November: Apostolos Apostolidis (Greece)
Reviewer of the Year 2009 Henk van der Poel (The Netherlands)
Vincenzo Ficarra (Italy)
2008 Reviewers of the Month January: Shahrokh Shariat (USA) February: Alberto Briganti (Italy) March: Alexander Bachmann (Switzerland) April: Scott Eggener (USA) May: Roger Dmochowski (USA) June: Felix K.-H. Chun (Germany) July: Giacomo Novara (Italy) August: Michael Blute (USA)
2010 Reviewers of the Month January: Ricarda Bauer (Germany) February: Declan Murphy (Australia) March: Harry Herr (USA) April: Marko Babjuk (Czech Republic) May: Umberto Capitanio (Italy) June: Stephen Freedland (USA) July: Richard Sylvester (Belgium) August: Rufus Cartwright (UK) September: Jens Rassweiler (Germany)